Loading…

P2.04-27 Ph II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in Patients with Advanced NSCLC

Saved in:

Bibliographic Details
Published in:	Journal of thoracic oncology 2018-10, Vol.13 (10), p.S741-S741
Main Authors:	Arce-Lara, C., Arriola, E., Brunsvig, P., Carcereny, E., Domine, M., Dragnev, K., Felip, E., García Campelo, R., Krebs, M., Paz-Ares, L., Ponce Aix, S., Spicer, J., Trigo, J.M., Vinolas Segarra, N., Holt, R., Micklem, D., Brown, A., Chisamore, M., Lorens, J.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!